James H. Quigley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James H. Quigley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James H. Quigley. James H. Quigley is Director in HESS CORP ($HES) and Director in WELLS FARGO & COMPANY/MN ($WFC) and Director in MERRIMACK PHARMACEUTICALS INC ($MACK).
Latest Insider Trading Transactions of James H. Quigley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HES, MACK, WFC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2021 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 2,332 | 0 | 5,852 | 3.5 K to 5.9 K (+66.25 %) |
| Mar 10 2020 | HES | HESS CORP | Quigley James H. | Director | Buy | P | 0.00 | 503 | 0 | 3,520 | 3 K to 3.5 K (+16.67 %) |
| Mar 10 2020 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 3,017 | 0 | 3,017 | 0 to 3 K |
| Apr 25 2019 | WFC | WELLS FARGO & COMP ... | Quigley James H. | Director | Option Exercise | A | 0.00 | 3,802 | 0 | 24,362 | |
| Mar 08 2019 | HES | HESS CORP | Quigley James H. | Director | Buy | P | 56.74 | 442 | 25,079 | 21,139 | 20.7 K to 21.1 K (+2.14 %) |
| Mar 08 2019 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 2,643 | 0 | 20,697 | 18.1 K to 20.7 K (+14.64 %) |
| Jun 15 2018 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 9.67 | 7,000 | 67,690 | 7,000 | |
| Apr 26 2018 | WFC | WELLS FARGO & COMP ... | Quigley James H. | Director | Option Exercise | A | 0.00 | 3,325 | 0 | 19,927 | |
| Apr 26 2018 | WFC | WELLS FARGO & COMP ... | Quigley James H. | Director | Grant | A | 0.00 | 103 | 0 | 2,390 | 2.3 K to 2.4 K (+4.50 %) |
| Mar 08 2018 | HES | HESS CORP | Quigley James H. | Director | Buy | P | 48.48 | 516 | 25,016 | 18,054 | 17.5 K to 18.1 K (+2.94 %) |
| Mar 08 2018 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 3,094 | 0 | 17,538 | 14.4 K to 17.5 K (+21.42 %) |
| Sep 15 2017 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 13.99 | 7,500 | 104,925 | 7,500 | |
| Apr 27 2017 | WFC | WELLS FARGO & COMP ... | Quigley James H. | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 16,134 | |
| Jun 16 2016 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 6.22 | 43,000 | 267,460 | 43,000 | |
| May 04 2016 | WFC | WELLS FARGO & ... | Quigley James H. | Director | Buy | P | 49.97 | 2,000 | 99,940 | 2,150 | 150 to 2.2 K (+1,333.33 %) |
| Apr 28 2016 | WFC | WELLS FARGO & ... | Quigley James H. | Director | Option Exercise | A | 0.00 | 3,535 | 0 | 12,477 | |
| Mar 03 2016 | HES | HESS CORP | Quigley James H. | Director | Buy | P | 44.21 | 567 | 25,067 | 11,041 | 10.5 K to 11 K (+5.41 %) |
| Mar 03 2016 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 3,393 | 0 | 10,474 | 7.1 K to 10.5 K (+47.92 %) |
| May 18 2015 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 11.88 | 14,000 | 166,320 | 14,000 | |
| Apr 30 2015 | WFC | WELLS FARGO & ... | Quigley James H. | Director | Option Exercise | A | 0.00 | 3,249 | 0 | 8,691 | |
| Mar 05 2015 | HES | HESS CORP | Quigley James H. | Director | Buy | P | 74.47 | 336 | 25,022 | 7,081 | 6.7 K to 7.1 K (+4.98 %) |
| Mar 05 2015 | HES | HESS CORP | Quigley James H. | Director | Grant | A | 0.00 | 2,014 | 0 | 6,745 | 4.7 K to 6.7 K (+42.57 %) |
| May 21 2014 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Buy | P | 6.58 | 5,000 | 32,900 | 56,500 | 51.5 K to 56.5 K (+9.71 %) |
| May 15 2014 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 6.63 | 30,268 | 200,677 | 30,268 | |
| Dec 09 2013 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Buy | P | 4.70 | 39,000 | 183,257 | 51,500 | 12.5 K to 51.5 K (+312.00 %) |
| Jun 13 2013 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 5.41 | 30,268 | 163,750 | 30,268 | |
| Aug 27 2012 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Option Exercise | A | 7.53 | 21,300 | 160,389 | 21,300 | |
| Aug 27 2012 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Buy | P | 7.55 | 12,200 | 92,110 | 12,500 | 300 to 12.5 K (+4,066.67 %) |
| Aug 27 2012 | MACK | MERRIMACK PHARMACE ... | Quigley James H. | Director | Buy | P | 7.50 | 300 | 2,250 | 300 | 0 to 300 |
Page: 1